Ischemic stroke is known as a neurodegenerative disorder, which induces long‐period tissue damage. Chemokine (C–X–C motif) ligand 8 (CXCL8) is involved in acute inflammation and tumor progression through the phosphoinositide‐3‐kinase/protein kinase B/nuclear factor‐κB (PI3K/Akt/NF‐κB)‐signaling pathway. In this study, we aimed to explore the mechanism of CXCL8 in ischemic stroke in relation to the PI3K/Akt/NF‐κB‐signaling pathway.

Microarray‐based gene expression profiling of peripheral blood mononuclear cells was used to identify ischemic stroke‐related differentially expressed genes and explore role of CXCL8 in ischemic stroke. Next, the ischemic mice model was successfully established, with transfection efficiency detected. After that, deflection index, recovery of nervous system, infarct sizes, ischemia‐induced apoptosis, and neuroinflammatory response in ischemic stroke were measured. At last, the content of inflammatory factors as well as the expression of CXCL8, caspase‐3, caspase‐9, Bad, interleukin‐6 (IL‐6), IL‐1β, tumor necrosis factor‐α (TNF‐α), Akt, PI3K, and NF‐κB were determined.

Comprehensive gene expression profiling analysis identified that CXCL8 might affect the development of ischemic stroke through regulating the PI3K/Akt/NF‐κB‐signaling pathway. CXCL8 silencing significantly reduced deflection index and infarct size, improved neurological function, and suppressed neuroglial cell loss and apoptosis index. In addition, glial fibrillary acidic portein (GFAP) and ionized calcium‐binding adapter molecule 1 (IBA‐1) expressions were decreased following CXCL8 suppression, suggesting CXCL8 affected neuroglial activation. Importantly, we also found that CXCL8 silencing activated neuroglial cell and suppressed inflammatory cytokine production in ischemic stroke mice.

Taken together, these findings highlight that functional suppression of CXCL8 promotes neuroglial activation and inhibits neuroinflammation by regulating the PI3K/Akt/NF‐κB‐signaling pathway in mice with ischemic stroke, which might provide new insight for ischemic stroke treatment.